Q2 2022 Aptose Biosciences Inc Earnings Call Transcript

Aug 02, 2022 / 09:00PM GMT
Operator

Good day, and thank you for standing by. Welcome to the Aptose Biosciences Inc. Reports Result for the Second Quarter of 2022. (Operator Instructions)

And I will now like to hand the conference over to Ms. Susan Pietropaolo. Ms. Pietropaolo, please go ahead.

Susan M. Pietropaolo - SMP Communications, Inc. - Principal

Thank you, Chris. Good afternoon and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the second quarter ended June 30, 2022. Earlier today, Aptose issued a press release relating to these financial results, the news release, as well as related SCC filings are accessible on Aptose's website. Joining me on today's call are Dr. William G. Rice, Chairman, President and CEO; Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer; and Mr. Fletcher Payne, Senior Vice President and Chief Financial Officer.

Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and Canadian

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot